What Is Biomems?

BioMEMS, or biomedical microelectromechanical systems, are microscale devices engineered to interface with biological systems or to perform biological measurements. They are typically manufactured using photolithography, etching, and deposition techniques adapted from semiconductor fabrication, and they range in size from a few micrometers to several millimeters. BioMEMS draws on electrical engineering, mechanical engineering, materials science, and cell biology, and the technology has become a central platform for point-of-care diagnostics, implantable sensors, and controlled drug delivery.

The field traces its origins to the broader MEMS discipline of the 1980s, but it gained its own identity as researchers recognized that mechanical miniaturization offered specific advantages for biological work: small fluid volumes that match the scale of cellular processes, fast reaction times in microscale channels, and low material costs per device when manufactured at wafer scale. A major review of MEMS devices for biomedical applications published in PMC outlines the scope of the field and the fabrication strategies that underpin it.

Microfabrication and Device Architecture

BioMEMS devices are built using the same photolithographic patterning processes used for integrated circuits, but the materials and process chemistries are adapted for biological compatibility. Silicon and glass remain common substrates because of their dimensional precision, but polymer materials such as polydimethylsiloxane (PDMS) and SU-8 photoresist are widely used for soft lithography, which allows channels and membranes to be replicated from masters in minutes at low cost. Biocompatibility requirements impose constraints not encountered in electronic fabrication: surfaces must resist protein adsorption, avoid cytotoxic leachables, and in some cases present biochemical ligands that promote cell adhesion or prevent it. Thin-film deposition of titanium nitride, parylene, and hydroxyapatite coatings extends the palette of surface chemistries available to device designers.

Lab-on-a-Chip and Microfluidics

Lab-on-a-chip devices integrate sample preparation, chemical reactions, separation, and detection into a single microfluidic chip, reducing the analytical workflow that once required a full laboratory to a small, portable platform. Microfluidic channels guide reagents and samples through controlled geometries, enabling precise control of mixing, reaction time, and particle sorting that is difficult to achieve at macroscale. Droplet microfluidics encapsulates individual cells or reagent mixtures in aqueous droplets surrounded by immiscible oil, allowing millions of parallel reactions in a single experiment. A paper on BioMEMS for biomedical drug delivery and analytical techniques published through PMC demonstrates how microfluidic integration enables controlled release profiles that conventional formulations cannot achieve. Microarrays, which print thousands of oligonucleotide or antibody probes in defined spots on a surface, use BioMEMS fabrication methods to achieve the spot sizes and densities required for high-throughput genomic and proteomic assays.

Implantable BioMEMS and Actuators

Implantable BioMEMS extend the technology from the laboratory to the patient body. Pressure sensors fabricated from piezoresistive silicon membranes can be embedded in catheters to measure intravascular or intraocular pressure, while electrochemical sensors monitor glucose in interstitial tissue. Neural probes with multiple recording sites etched from silicon or polymer substrates enable high-density electrophysiology in the brain. Actuator devices use electrostatic, piezoelectric, or thermopneumatic mechanisms to deliver controlled fluid volumes from implanted drug reservoirs, a capability with direct implications for tissue engineering applications documented in PMC.

Applications

BioMEMS has applications in a range of fields, including:

• Point-of-care infectious disease diagnostics using integrated microfluidic assay chips
• Continuous glucose monitoring with implantable electrochemical sensors
• High-throughput genomic and proteomic analysis via DNA and protein microarrays
• Controlled and targeted drug delivery through implantable microreservoir actuators
• Neuroscience research using silicon multielectrode arrays for brain recording